PLRX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 107978 min ago

@ $16.43

Wydano: 14 vas. 2024 @ 22:44

Zwrot: -26.39%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: 5.47 %

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	238 975
Średni wolumen	371 556
Kapitalizacja rynkowa	729.25M
EPS	$-0.690 ( 2024-03-28 )
Następna data zysków	( $-0.770 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.40
ATR14	$0.0130 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Lefebvre Eric	Buy	42 900	Common Stock
2024-01-23	Lefebvre Eric	Buy	85 800	Stock Option (Right to Buy)
2024-01-23	Hull Hans	Buy	31 500	Common Stock
2024-01-23	Hull Hans	Buy	63 000	Stock Option (Right to Buy)
2024-01-23	Ouimette Mike	Buy	31 500	Common Stock

INSIDER POWER
67.14
Last 98 transactions
Buy: 2 502 892 \| Sell: 552 083

Wolumen Korelacja

Długi: 0.02 (neutral)

Krótki: -0.39 (neutral)

Signal:(42.312) Neutral

Pliant Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
PAIC	0.955
CSII	0.935
ADMS	0.932
RESN	0.927
HSKA	0.921
ZGNX	0.918
OLMA	0.915
NATI	0.914
IPW	0.912
SVAC	0.911

10 Najbardziej negatywne korelacje
NETE	-0.945
BOCH	-0.932
MMAC	-0.914
RAVN	-0.912
SHSP	-0.879
SBBP	-0.876
CFV	-0.873
AMRB	-0.869
ORMP	-0.869
AZTA	-0.861

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pliant Therapeutics Inc Korelacja - Waluta/Towar

-0.27
( neutral )

-0.17
( neutral )

0.00
( neutral )

-0.50
( neutral )

0.73
( moderate )

-0.54
( weak negative )

Pliant Therapeutics Inc Finanse

Annual	2023
Przychody:	$1.58M
Zysk brutto:	$-261 000 (-16.52 %)
EPS:	$-2.75

FY	2023
Przychody:	$1.58M
Zysk brutto:	$-261 000 (-16.52 %)
EPS:	$-2.75

FY	2022
Przychody:	$9.69M
Zysk brutto:	$6.00M (61.99 %)
EPS:	$-2.89

FY	2021
Przychody:	$7.57M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.71

Financial Reports:

No articles found.

Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.